Maxim Yankelevich

580 citations
20 papers · 192 indexed · h-index 7
Topics
Neutropenia and Cancer Infections (8 papers)Hematopoietic Stem Cell Transplantation (7 papers)Neuroblastoma Research and Treatments (5 papers)

In The Last Decade

Maxim Yankelevich

19 papers receiving 188 citations

Peers

Maxim Yankelevich
Comparison fields: 5 of 38
  • Oncology 103
  • Genetics 50
  • Neurology 50
  • Molecular Biology 49
  • Immunology 43
Replace A. Audemard with:
A. Audemard France
Aysche Landmann Germany
Renee H. Grau United States
Sara Pérez‐Jaume Spain
Seongmin Choi South Korea
Nicholas Coupe United Kingdom
Jasmin Lisfeld Germany
Julia Balaguer Spain
Harry Miao United States
Halldora K. Thorarinsdottir United States
Maxim Yankelevich relative to A. Audemard France A. Audemard's profile →
Citations per field
00.5×2.8×
A. Audemard · 1×
Citations per year

Countries citing papers authored by Maxim Yankelevich

Since Specialization
Citations

This map shows the geographic impact of Maxim Yankelevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Yankelevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Yankelevich more than expected).

Fields of papers citing papers by Maxim Yankelevich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Yankelevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Yankelevich. The network helps show where Maxim Yankelevich may publish in the future.

Co-authorship network of co-authors of Maxim Yankelevich

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Yankelevich. A scholar is included among the top collaborators of Maxim Yankelevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Yankelevich. Maxim Yankelevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 1
3 6
4 2
5 1
6 2
7 1
8 2
9 13
10 0
11 40
12 5
13 6
14 10
15 61
16 19
17 2
18 1
19 6
20 2

About Maxim Yankelevich

Maxim Yankelevich is a scholar working on Hematology, Oncology and Neurology, having authored 20 papers that have together received 192 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Genetics (50 citations), Oncology (103 citations) and Neurology (50 citations). Maxim Yankelevich has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Lawrence G. Lum, Archana Thakur, Steven Buck, Sri Vidya Kondadasula, Nai‐Kong V. Cheung, Margaret A. Goodell, Joseph Kaplan, Jonathan L. Finlay, Wafik Zaky and Vedat Yildiz. Their work appears in journals such as Journal of Clinical Oncology, Blood and Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026